Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
1,472,973
-
Share change
-
+1,472,248
-
Total reported value
-
$20,679,000
-
Price per share
-
$14.02
-
Number of holders
-
15
-
Value change
-
+$20,669,000
-
Number of buys
-
14
Institutional Holders of NEURODERM LTD - ORD SHS as of Q4 2014
As of 31 Dec 2014 NEURODERM LTD - ORD SHS had 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,472,973 shares of stock of the company.
Largest 10 holders included ADAGE CAPITAL PARTNERS GP LLC, PERCEPTIVE ADVISORS LLC, BAKER BROS. ADVISORS LP, Alyeska Investment Group, L.P., OPPENHEIMER & CO INC, Citadel Advisors LLC, GOLDMAN SACHS GROUP INC, KCG Holdings, Inc., MORGAN STANLEY, and DEUTSCHE BANK AG\.
This table shows 15 institutional shareholders of the security as of 31 Dec 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.